Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PHVS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Viviane Monges Director | PHVS Pharvaris N.V. | Sale | 11,969 | $33.05 | $395.6K Sale | Form 4 ↗ |
| Sep 22, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 800 | $36.19 | $29.0K Sale | Form 4 ↗ |
| Sep 21, 2026 | David W. Nassif CFO / CLO | PHVS Pharvaris N.V. | Sale | 6,000 | $36.47 | $218.8K Sale | Form 4 ↗ |
| Sep 17, 2026 | Peng Lu President | PHVS Pharvaris N.V. | Sale | 100,000 | $35.00 | $3.5M Sale | Form 4 ↗ |
| Sep 17, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 200,000 | $35.00 | $7.0M Sale | Form 4 ↗ |
| Sep 17, 2026 | Elisabeth Bjork Director | PHVS Pharvaris N.V. | Sale | 52,500 | $37.89 | $2.0M Sale | Form 4 ↗ |
| Sep 17, 2026 | Robert Glassman Director | PHVS Pharvaris N.V. | Sale | 14,493 | $38.56 | $558.9K Sale | Form 4 ↗ |
| Sep 17, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 20,000 | $38.27 | $765.4K Sale | Form 4 ↗ |
| Sep 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | PHVS Pharvaris N.V. | Sale | 1,400 | $39.24 | $54.9K Sale | Form 4 ↗ |
| Sep 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | PHVS Pharvaris N.V. | Sale | 45,000 | $38.14 | $1.7M Sale | Form 4 ↗ |
| Sep 15, 2026 | Robert Glassman Director | PHVS Pharvaris N.V. | Sale | 8,667 | $38.27 | $331.7K Sale | Form 4 ↗ |
| Sep 15, 2026 | Wim Souverijns Chief Commercial Officer | PHVS Pharvaris N.V. | Sale | 6,090 | $38.99 | $237.4K Sale | Form 4 ↗ |
| Sep 14, 2026 | Wim Souverijns Chief Commercial Officer | PHVS Pharvaris N.V. | Sale | 20,000 | $39.31 | $786.2K Sale | Form 4 ↗ |
| Sep 14, 2026 | Berndt Modig Chief Executive Officer, Director | PHVS Pharvaris N.V. | Sale | 2,291 | $39.40 | $90.3K Sale | Form 4 ↗ |
| Sep 11, 2026 | Peng Lu President | PHVS Pharvaris N.V. | Sale | 15,000 | $40.13 | $602.0K Sale | Form 4 ↗ |
| Sep 10, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 30,000 | $38.30 | $1.1M Sale | Form 4 ↗ |
| Sep 9, 2026 | Robert Glassman Director | PHVS Pharvaris N.V. | Sale | 8,000 | $37.55 | $300.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Peng Lu President | PHVS Pharvaris N.V. | Sale | 15,000 | $40.68 | $610.2K Sale | Form 4 ↗ |
| Aug 14, 2026 | Berndt Modig Chief Executive Officer, Director | PHVS Pharvaris N.V. | Sale | 2,292 | $34.77 | $79.7K Sale | Form 4 ↗ |
| Jul 13, 2026 | Berndt Modig Chief Executive Officer, Director | PHVS Pharvaris N.V. | Sale | 2,292 | $34.97 | $80.2K Sale | Form 4 ↗ |
| Jun 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 30,712 | $35.49 | $1.1M Sale | Form 4 ↗ |
| Jun 30, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 30,703 | $35.49 | $1.1M Sale | Form 4 ↗ |
| Jun 30, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 27,872 | $35.48 | $988.9K Sale | Form 4 ↗ |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 6,888 | $35.05 | $241.4K Sale | Form 4 ↗ |
| Jun 29, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 6,997 | $35.05 | $245.2K Sale | Form 4 ↗ |
| Jun 29, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 8,300 | $35.05 | $290.9K Sale | Form 4 ↗ |
| Jun 29, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 2,300 | $35.12 | $80.8K Sale | Form 4 ↗ |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 2,400 | $35.10 | $84.2K Sale | Form 4 ↗ |
| Jun 26, 2026 | Peng Lu Chief Medical Officer | PHVS Pharvaris N.V. | Sale | 14,700 | $34.00 | $499.8K Sale | Form 4 ↗ |
| Jun 25, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 2,300 | $35.12 | $80.8K Sale | Form 4 ↗ |
| Jun 25, 2026 | Anne Lesage Chief Early Development | PHVS Pharvaris N.V. | Sale | 2,300 | $35.12 | $80.8K Sale | Form 4 ↗ |
| Jun 25, 2026 | Peng Lu Chief Medical Officer | PHVS Pharvaris N.V. | Sale | 3,400 | $35.09 | $119.3K Sale | Form 4 ↗ |
| Jun 25, 2026 | Peng Lu Chief Medical Officer | PHVS Pharvaris N.V. | Sale | 11,600 | $34.45 | $399.6K Sale | Form 4 ↗ |
| Jun 18, 2026 | Peng Lu Chief Medical Officer | PHVS Pharvaris N.V. | Sale | 300 | $34.00 | $10.2K Sale | Form 4 ↗ |
| Jun 15, 2026 | Berndt Modig Chief Executive Officer, Director | PHVS Pharvaris N.V. | Sale | 100 | $31.46 | $3,146 Sale | Form 4 ↗ |
| Jun 15, 2026 | Berndt Modig Chief Executive Officer, Director | PHVS Pharvaris N.V. | Sale | 2,191 | $31.05 | $68.0K Sale | Form 4 ↗ |
| Jun 4, 2026 | Anna Nijdam Principal Accounting Officer | PHVS Pharvaris N.V. | Sale | 2,670 | $30.87 | $82.4K Sale | Form 4 ↗ |
| May 22, 2026 | Anna Nijdam Principal Accounting Officer | PHVS Pharvaris N.V. | Sale | 5,501 | $30.74 | $169.1K Sale | Form 4 ↗ |
| May 21, 2026 | Viviane Monges Director | PHVS Pharvaris N.V. | Sale | 9,667 | $30.29 | $292.8K Sale | Form 4 ↗ |
| May 21, 2026 | Anna Nijdam Principal Accounting Officer | PHVS Pharvaris N.V. | Sale | 1,829 | $30.60 | $56.0K Sale | Form 4 ↗ |
| May 21, 2026 | David W. Nassif CFO / CLO | PHVS Pharvaris N.V. | Sale | 10,000 | $30.31 | $303.1K Sale | Form 4 ↗ |
| May 20, 2026 | Elisabeth Bjork Director | PHVS Pharvaris N.V. | Sale | 10,000 | $29.32 | $293.2K Sale | Form 4 ↗ |
| May 15, 2026 | Robert Glassman Director | PHVS Pharvaris N.V. | Sale | 4,667 | $29.82 | $139.2K Sale | Form 4 ↗ |
| May 15, 2026 | Robert Glassman Director | PHVS Pharvaris N.V. | Sale | 5,333 | $29.83 | $159.1K Sale | Form 4 ↗ |
| May 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | PHVS Pharvaris N.V. | Sale | 8,748 | $29.82 | $260.9K Sale | Form 4 ↗ |
| May 15, 2026 | Wim Souverijns Chief Commercial Officer | PHVS Pharvaris N.V. | Sale | 10,000 | $29.92 | $299.2K Sale | Form 4 ↗ |
| May 1, 2026 | Peng Lu Chief Medical Officer | PHVS Pharvaris N.V. | Sale | 143 | $31.00 | $4,433 Sale | Form 4 ↗ |
| May 1, 2026 | Peng Lu Chief Medical Officer | PHVS Pharvaris N.V. | Sale | 14,023 | $30.16 | $422.9K Sale | Form 4 ↗ |
| Apr 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 670 | $31.03 | $20.8K Sale | Form 4 ↗ |
| Apr 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | PHVS Pharvaris N.V. | Sale | 28,400 | $30.30 | $860.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances